These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7882142)

  • 21. Recognition of hairpin-containing single-stranded DNA by oligonucleotides containing internal acridine derivatives.
    François JC; Hélène C
    Bioconjug Chem; 1999; 10(3):439-46. PubMed ID: 10346876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
    Mahon FX; Ripoche J; Pigeonnier V; Jazwiec B; Pigneux A; Moreau JF; Reiffers J
    Exp Hematol; 1995 Dec; 23(14):1606-11. PubMed ID: 8542954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of mRNA self-structure on hybridization: computational tools for antisense sequence selection.
    Toschi N
    Methods; 2000 Nov; 22(3):261-9. PubMed ID: 11071822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of the Escherichia coli primase/single-strand DNA-binding protein/phage G4oric complex required for primer RNA synthesis.
    Sun W; Godson GN
    J Mol Biol; 1998 Mar; 276(4):689-703. PubMed ID: 9500915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of high-stringency DNA hairpin probes by partial gene folding.
    Strohsahl CM; Krauss TD; Miller BL
    Biosens Bioelectron; 2007 Sep; 23(2):233-40. PubMed ID: 17512187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
    Lima WF; Crooke ST
    Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of RNA function by oligonucleotides recognizing RNA structure.
    Toulmé JJ; Di Primo C; Moreau S
    Prog Nucleic Acid Res Mol Biol; 2001; 69():1-46. PubMed ID: 11550792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
    Oberbauer R
    Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting RNA structures by antisense oligonucleotides.
    Toulmé JJ; Tinévez RL; Brossalina E
    Biochimie; 1996; 78(7):663-73. PubMed ID: 8955909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The binding of an antisense oligonucleotide to a hairpin structure via triplex formation inhibits chemical and biological reactions.
    Brossalina E; Pascolo E; Toulmé JJ
    Nucleic Acids Res; 1993 Dec; 21(24):5616-22. PubMed ID: 8284206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technical improvements in the computational target search for antisense oligonucleotides.
    Far RK; Leppert J; Frank K; Sczakiel G
    Oligonucleotides; 2005; 15(3):223-33. PubMed ID: 16201910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell membranes as barriers for antisense constructions.
    Budker VG; Knorre DG; Vlassov VV
    Antisense Res Dev; 1992; 2(2):177-84. PubMed ID: 1382741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo antisense imaging.
    Tavitian B
    Q J Nucl Med; 2000 Sep; 44(3):236-55. PubMed ID: 11105588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymerase-endonuclease amplification reaction (PEAR) for large-scale enzymatic production of antisense oligonucleotides.
    Wang X; Gou D; Xu SY
    PLoS One; 2010 Jan; 5(1):e8430. PubMed ID: 20062528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA oligomers having a diazapyrenium dication (DAP2+); synthesis and DNA cleavage activities.
    Ikeda H; Fuji K; Tanaka K; Iso Y; Yoneda F
    Chem Pharm Bull (Tokyo); 1999 Oct; 47(10):1455-63. PubMed ID: 10553642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular oligo targeting. A theoretical dissertation.
    Chuang TT
    Ann N Y Acad Sci; 1992 Oct; 660():326-7. PubMed ID: 1340148
    [No Abstract]   [Full Text] [Related]  

  • 39. Corrigendum to "From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides".
    Mol Ther Nucleic Acids; 2016 Nov; 5(11):e391. PubMed ID: 27898093
    [No Abstract]   [Full Text] [Related]  

  • 40. Publisher Correction: Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry.
    Terada C; Oh K; Tsubaki R; Chan B; Aibara N; Ohyama K; Shibata MA; Wada T; Harada-Shiba M; Yamayoshi A; Yamamoto T
    Nat Commun; 2024 Jan; 15(1):271. PubMed ID: 38177153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.